Common oncogenes and tumour suppressor genes whose CNA statuses were confirmed to have association with the disease stage at a p-value of <0.05 in this study included CCND1, CCNE1, CDKN1B, CDKN2A, CHD1, MYC, PIK3CA, PTEN, RB1, FGFR1, BCL2, and TP53. In addition, the PCa-specific genes confirmed to have significant associations with the disease stage included AR, NCOR1, NCOR2, FOXA1, MED12, ERG, ETV4, ETV6, and TMPRSS2. This evidence concerns the gene CDKN2A and posterior cortical atrophy.